Our Advisory Board serves as a brain trust, offering
leadership, industry contacts and resources
Maxmillian Angerholzer III is Executive Vice President of the Institute of International Education (IIE). Headquartered in New York, IIE is the world’s premier non-profit global education organization with 18 offices and more than 700 employees worldwide. Mr. Angerholzer previously served as President & CEO of the Center for the Study of the Presidency & Congress (CSPC) in Washington, D.C. A non-partisan policy organization established in 1965, CSPC applies lessons of leadership and history to current domestic and international challenges and promotes cooperation between The White House, Congress, and the private sector. Mr. Angerholzer was also Managing Director of the Richard Lounsbery Foundation, a New York philanthropic institution that awards grants to support scientific and medical research, as well as science and technology policy, education, international relations, and security programs.

Brian J. Brille is a Managing Partner of lifestyle healthcare-focused growth equity firm Strathspey Crown Holdings LLC. Additionally, he serves as the Chairman and Managing Partner of Crown Sterling LLC, a subsidiary of Strathspey Crown focused on serving the physician community. Previously, Mr. Brille was the Chairman of the Asia Pacific Region for Banc of America Merrill Lynch and a Managing Director and Head of Healthcare Services Investment Banking at Morgan Stanley & Co., Inc.

Andrew Brooks, Ph.D. is the Chief Operating Officer of the Rutgers University Cell and DNA Repository (RUCDR) and Director of the Bionomics Research and Technology Center (BRTC) at the Environmental and Occupational Health Science Institute of the University of Medicine and Dentistry of New Jersey.

Gregory H. Epstein, PH.D., ESQ. is an attorney in the Healthcare and Life Sciences practice at Epstein, Becker, & Green, P.C. He has been a Venture Advisor with Radius since 2013. Mr. Epstein regularly works with payers, providers, and healthcare companies on a range of strategic, regulatory, and commercialization issues. Mr. Epstein is on the Board of Directors of Fallon Health Weinberg (Fallon Health) and on the Board of Advisors of Healthsense, a Radius portfolio company.

Steven B. Epstein, Esq. is the founder of Epstein Becker & Green, one of the largest national healthcare law firms in the United States. As a Senior Partner of the firm, he provides healthcare organizations and providers with strategic legal guidance on a range of issues and legal challenges relating to the American healthcare system.

Jeffrey P. Freimark, Esq., CPA is the President and CEO of Miami Jewish Health Systems one of the largest healthcare providers in the Southeast, with a primary focus on the fragile elderly. Previously, Mr. Freimark served as President, CEO and CFO of Grand Union Company, a $2.3 billion public corporation operating full service retail supermarkets in the Northeast United States, Senior EVP and CFO for OfficeMax, EVP, CFO & CIO for Beverly Enterprises and EVP, CFO & CIO for Intelsat, the largest operator of commercial satellites in the world.

Scott T. Garrett is the former President and CEO of Beckman Coulter. Previously, Mr. Garrett served as CEO of Kendro Laboratory Products and Dade Behring. Mr. Garrett currently serves as an Operating Partner at Water Street Healthcare Partners.

Robert M. Guezuraga is the former President of several Medtronic operating divisions including Diabetes (Minimed), Cardiac Surgery and Physio-Control; he also served as Senior Vice President of Medtronic and on Medtronic's Executive Committee. Mr. Guezuraga has also served as a Senior Consultant to Bain Capital and currently serves as Managing Director and Founder of RMG, LLC, a private investment management firm.

James I. McLaren is a Managing Director of TM Capital Corp., where he leads Asanté Healthcare Partners (the healthcare practice of TM Capital). He joined TM Capital from Asanté Partners, which he founded in 1992 at EGS Securities Corp. Prior to Asanté, Mr. McLaren was with Goldman Sachs, where he served as head of European Corporate Finance in London and of International Corporate Finance in New York.

Thomas F. O'Donnell, Jr., M.D. is the former President and CEO, and current Senior Vascular Surgeon at Tufts Medical Center and the Benjamin Andrews Professor of Surgery Emeritus at Tufts University School of Medicine.

Mehmet C. Oz, M.D. is Vice-Chair and Professor of Surgery at Columbia University. He directs the Cardiovascular Institute and Complementary Medicine Program at New York Presbyterian Hospital. Dr. Oz has authored seven New York Times Best Sellers and over 400 original publications. He currently hosts the “The Dr. Oz Show" and a daily talk show on Sirius XM.

Stephen G. Pagliuca is a Managing Director of Bain Capital. He is the co-managing partner and co-owner of the Boston Celtics, and serves on several corporate boards, including Hospital Corporation of America (HCA), Gartner Group, and Burger King Corp.

David R. Pitts is the Chairman, Chief Executive Officer, and Founder of Pitts Management Associates (PMA), a national hospital and healthcare management and consulting firm. Prior to founding PMA, he was the CEO of the Ochsner Foundation Hospital in New Orleans, and served as the Executive Officer for Health Affairs in the Office of the Secretary of Defense. He is the founder and President of Health Insights.

Kathleen Regan is the EVP & COO of The Commonwealth Fund. Ms. Regan was a Venture Partner with Radius from 2010 – 2014 and has been investing in and advising healthcare companies for the past 25 years. Prior to joining Radius, Ms. Regan was the EVP of Keystone Dental, Inc., served as a consultant to Warburg Pincus, where she was involved in investing with the medical technology team and served as a board member to several portfolio companies, a Senior Managing Director and Director of Healthcare Investment Banking at SunTrust Robinson Humphrey LLC and, previously, a Managing Director at Freedom Securities Tucker Anthony.

R. Timothy Rice is the Chief Executive Officer Emeritus of Cone Health. Previously Mr. Rice served as CEO and COO of Cone Health, Executive Vice President of The Moses H. Cone Memorial Hospital and as Executive Vice President of the Health Services Division. Mr. Rice is a Fellow in the American College of Healthcare Executives and a member of the Board of Governors of the Center for Creative Leadership.

Jan Rock is formerly VP of Women's Health at Johnson & Johnson (J&J). At J&J, she was responsible for expanding the company's two billion dollar franchise in women's health products. Ms. Rock formerly served on the board of directors of U-Systems and currently serves as a Vice Chairman of the board of trustees of Cornell University.

Vinod K. Sahney, Ph.D. is formerly SVP and Chief Strategy Officer of Blue Cross Blue Shield of Massachusetts. Prior to joining Blue Cross, he served as SVP and Chief Strategy Officer at Henry Ford Health System. He is a founding member of the Institute for Healthcare Improvement (IHI), where he served as Chairman of the Board of Directors. As well, he is an Adjunct Professor at Harvard University's Executive Program in Health Policy and Management.

Mark S. Speers is Managing Director and co-founder of Health Advances, a strategy consulting firm focused on the evaluation and commercialization of new medical technologies and services. Previously, Mr. Speers was a Partner at Bain & Company.

R. Scott Walker is the Executive Vice President and Chief Financial Officer of Fallon Community Health Plan a nationally recognized not-for-profit Health Maintenance Organization. Previously, Mr. Walker served as CFO of Complex Care Solutions, Inc. (formerly HC Innovations, Inc.), CFO of National Accounts and Business Alliances at Aetna, Inc., and Vice President, Controller & Chief Accounting Officer at Uniprise (a UnitedHealth Group Company).

James G. Wetrich, FACHE is the CEO of the Wetrich Group, which provides a broad range of healthcare advisory, marketing, strategy and human capital management consulting services. Most recently (2006-2014), he served as President of U.S. and Latin America, Wound Care for Molnlycke Health Care (MHC). Under his leadership, MHC's market share in advanced wound care grew substantially - from number five in the market to number one.